APOE and Alzheimer disease: Several studies have shown that APOE ε4 AD patients have a higher risk of CMBs and white matter lesions, showing that APOE ε 4 reduces the integrity of amyloid-damaged cerebral vasculature, increasing the risk of stroke and cerebral haemorrhage [32, 33].